About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Tanezumab in Osteoarthritis of the Hip or Knee (2)

Tanezumab in Osteoarthritis of the Hip or Knee (2)

NCT00863304·95 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Osteoarthritis of the hip or knee according to Kellgren-Lawrence x-ray grade of 2

You may not be if

pregnancy or intent to become pregnant
BMI greater than 39
other severe pain, significant cardiac, neurological or psychiatric disease

The record

StatusCompleted

PhasePhase 3

Taking part849

StartedJun 2009

UpdatedMay 17, 2021

Conditions

Where95

Greystone Medical Research, LLC
Birmingham, Alabama, United States
Saadat Ansari, MD
Huntsville, Alabama, United States
Coastal Clinical Research, Inc.
Mobile, Alabama, United States